CDKN3 and non-small cell lung carcinoma: Using these criteria, and in consideration of previously published work [52, 60–62], we selected the transcription factor FoxO1 and cyclin-dependent kinase inhibitor p27 as effectors of miR-196a in NSCLC cells.